Skip to main content
. 2021 May 27;11:11133. doi: 10.1038/s41598-021-90496-w

Table 1.

List of recently identified 17 circulating KRIS proteins associated with risk of development of ESKD (14) and their corresponding intracellular and extracellular protein levels (expressed as fold changes) following TNFα treatment and hyperglycemia condition.

Protein name Gene symbol Intracellular Extracellular
Fold change p value Fold change p value
TNF-RSF members
TNF receptor superfamily member 1A TNFR1 1.00 n.s 0.37 6.2 × 10−6
TNF receptor superfamily member 1B TNFR2 1.06 n.s 0.99 n.s
TNF receptor superfamily member 21 TNFRSF21 0.81 n.s 0.61 2.7 × 10−3
TNF receptor superfamily member 19 TNFRSF19 0.99 n.s 0.98 n.s
TNF receptor superfamily member 27 EDA2R 1.05 n.s 1.10 n.s
TNF receptor superfamily member 19L RELT 0.87 n.s 0.91 n.s
Other proteins
Interleukin-15 receptor subunit alpha IL15RA 1.02 n.s 1.14 n.s
Interleukin-17F IL17F 1.20 n.s 1.06 n.s
Complement decay-accelerating factor CD55 1.13 n.s 0.83 n.s
CMRF35-like molecule 6 CD300C 1.01 n.s 0.92 2.6 × 10−3
TNF ligand superfamily member 15 TNFSF15 1.12 n.s 0.93 n.s
C–C motif chemokine 14 CCL14 0.61 8.8 × 10−5 0.15 1.9 × 10−5
C–C motif chemokine 15 CCL15 0.95 n.s 1.01 n.s
Macrophage colony-stimulating factor 1 CSF1 0.93 n.s 1.36 n.s
Hepatitis A virus cellular receptor 2 HAVCR2 1.03 n.s 0.97 n.s
Interleukin-1 receptor type 1 IL1R1 0.98 n.s 1.01 n.s
Interleukin-18 receptor 1 IL18R1 2.81 4.5 × 10−6 1.81 6.8 × 10−5

TNF, tumor necrosis factor; TNF-RSF, tumor necrosis factor receptor superfamily; n.s., not significant. Fold changes indicated in bold text indicate differentially expressed proteins at the Bonferroni’s correction α = 2.9 × 10−3 (Bonferroni’s correction for 17 KRIS proteins). Fold change is a ratio of a mean RFU concentration of a protein in HUVECs incubated with TNFα in hyperglycemia to a mean RFU concentration of a protein in HUVECs cultured in hyperglycemia.